It seems to me that Janssen has the infrastructure and service capability to function for us in a broader scope, if we are having difficulty with PCI Pharma. They may not have the scale we were looking for, but I wanted to see more focus on the EU than the UK, anyway.
There may be a crucial function we need PCI for, that I am not aware of.
But I like focus being placed on executing a stock split, not diverted by an issue with PCI.
I don't think anything is more important than executing the stock split, which I was hoping to see tomorrow, or the next day, or...
I hope we can legitimately re-focus on the stock split as our highest priority.